1. Home
  2. PDO vs OGN Comparison

PDO vs OGN Comparison

Compare PDO & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PIMCO Dynamic Income Opportunities Fund of Beneficial Interest

PDO

PIMCO Dynamic Income Opportunities Fund of Beneficial Interest

SELL

Current Price

$11.93

Market Cap

1.7B

Sector

Finance

ML Signal

SELL

Logo Organon & Co.

OGN

Organon & Co.

SELL

Current Price

$13.79

Market Cap

1.5B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
PDO
OGN
Founded
2020
1923
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.5B
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
PDO
OGN
Price
$11.93
$13.79
Analyst Decision
Hold
Analyst Count
0
5
Target Price
N/A
★ $11.25
AVG Volume (30 Days)
1.2M
★ 1.9M
Earning Date
01-01-0001
11-09-2026
Dividend Yield
★ 11.80%
0.58%
EPS Growth
★ N/A
N/A
EPS
N/A
★ 0.95
Revenue
N/A
★ $6,216,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$2.51
P/E Ratio
★ N/A
$14.49
Revenue Growth
★ N/A
N/A
52 Week Low
$11.51
$5.69
52 Week High
$14.20
$13.83

Technical Indicators

Market Signals
Indicator
PDO
OGN
Relative Strength Index (RSI) 45.21 58.45
Support Level $11.51 $13.46
Resistance Level $13.23 N/A
Average True Range (ATR) 0.20 0.04
MACD 0.05 0.01
Stochastic Oscillator 50.00 57.69

Price Performance

Historical Comparison
PDO
OGN

About PDO PIMCO Dynamic Income Opportunities Fund of Beneficial Interest

PIMCO Dynamic Income Opportunities Fund is a closed-end management investment company. The fund's primary objective is to generate current income, with capital appreciation as a secondary objective. It employs a flexible, multi-sector investment strategy across credit markets, investing in a wide range of income-producing debt securities. The fund actively adjusts allocations to capitalize on opportunities across different economic cycles and market conditions.

About OGN Organon & Co.

Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.

Share on Social Networks: